Institutional members access full text with Ovid®

Share this article on:

Less Focus on LDL in New CVD Prevention Guidelines

Lomangino, Kevin

doi: 10.1097/01.NMD.0000442584.04932.0a
Articles
KEY MESSAGES 
  • For most patients, decisions regarding cholesterol-lowering drug therapy should be based on an overall cardiovascular risk score, not LDL cholesterol levels, according to new U.S. guidelines.
  • Patients with a 10-year cardiovascular risk of 7.5% are now candidates for drug therapy—a threshold that will expand the population advised to consider statins.
  • Patients at an increased risk of cardiovascular disease are advised to reduce saturated fat intake to 5% to 6% of energy, avoid red meat, and follow a risk-reducing dietary pattern.

Mr. Lomangino is Editor, Clinical Nutrition Insight; E-mail: kevinl@maine.rr.com.

Mr. Lomangino has disclosed that he is a consultant to the Informed Medical Decisions Foundation and the American Association of Diabetes Educators.

© 2014 by Lippincott Williams & Wilkins, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website